financetom
Business
financetom
/
Business
/
Mira Murati's AI startup Thinking Machines valued at $12 billion in early-stage funding
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mira Murati's AI startup Thinking Machines valued at $12 billion in early-stage funding
Jul 15, 2025 10:33 AM

July 15 (Reuters) - Thinking Machines Lab, the

artificial intelligence startup founded by former OpenAI

executive Mira Murati, said on Tuesday it has raised about $2

billion at a valuation of $12 billion in a funding round led by

venture capital firm Andreessen Horowitz.

The fundraise also saw participation from AI chip giant

Nvidia ( NVDA ), Accel, ServiceNow ( NOW ), Cisco ( CSCO ), AMD

and Jane Street, the startup said.

The massive funding round for a company launched only in

February, with no revenue or products yet, underscores Murati's

ability to attract investors in a sector where top executives

have become coveted targets in an escalating talent war.

"We're excited that in the next couple months we will be

able to share our first product, which will include a

significant open source component and be useful for researchers

and startups developing custom model," CEO Murati said in a post

on the X social media platform.

Reuters had reported in April Andreessen Horowitz was in

talks to lead an outsized early-stage funding round.

Thinking Machines has said it wants to build artificial

intelligence systems that are safer, more reliable and aimed at

a broader number of applications than rivals. Nearly two-thirds

of its team at launch comprised of former OpenAI employees.

Murati, who started Thinking Machines after an abrupt exit

from OpenAI last September, is among a growing list of former

executives from the ChatGPT maker who have launched AI startups.

Another two, Dario Amodei's Anthropic and Ilya Sutskever's

Safe Superintelligence, have attracted former OpenAI researchers

and raised billions of dollars in funding.

Investor enthusiasm toward new AI startups has stayed

strong, despite some questions about tech industry spending.

That helped U.S. startup funding surge nearly 76% to $162.8

billion in the first half of 2025, with AI accounting for about

64.1% of the total deal value, according to a Pitchbook report.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved